Browse > Article
http://dx.doi.org/10.5230/jgc.2013.13.1.58

Five-Year Survival of Alpha-Fetoprotein-Producing Gastric Cancer with Synchronous Liver Metastasis: A Case Report  

Koneri, Kenji (Department of Gastroenterological Surgery, University of Fukui)
Hirono, Yasuo (Department of Gastroenterological Surgery, University of Fukui)
Fujimoto, Daisuke (Department of Gastroenterological Surgery, University of Fukui)
Sawai, Katsuji (Department of Gastroenterological Surgery, University of Fukui)
Morikawa, Mitsuhiro (Department of Gastroenterological Surgery, University of Fukui)
Murakami, Makoto (Department of Gastroenterological Surgery, University of Fukui)
Goi, Takanori (Department of Gastroenterological Surgery, University of Fukui)
Iida, Atsushi (Department of Gastroenterological Surgery, University of Fukui)
Katayama, Kanji (Cancer Care Promotion Center, University of Fukui)
Yamaguchi, Akio (Department of Gastroenterological Surgery, University of Fukui)
Publication Information
Journal of Gastric Cancer / v.13, no.1, 2013 , pp. 58-64 More about this Journal
Abstract
Alpha-fetoprotein-producing gastric cancer is associated with poor prognosis because of frequent liver and lymph node metastasis. We present a case with synchronous liver metastasis who survived for 5 years. A 69-year-old man with upper abdominal pain was referred to our hospital. Gastrointestinal endoscopy revealed a Borrmann II-like tumor in the lower part of the stomach. Computed tomography revealed a tumor in the left lobe of the liver. Serum alpha-fetoprotein levels were markedly increased. We performed distal gastrectomy after administering oral tegafur/gimeracil/oteracil potassium and administered hepatic intra-arterial cisplatin injection. Liver metastasis showed partial response on computed tomography. Despite left hepatic lobectomy, further metastases to the liver and mediastinal lymph nodes became difficult to control. After sorafenib tosylate administration, stabilization of the disease was observed for 4 months. We conclude that hepatic intra-arterial chemotherapy and oral administration of sorafenib tosylate may potentially improve the prognosis in such cases.
Keywords
Stomach neoplasms; Alpha-fetoproteins; Drug therapy; General surgery; Sorafenib;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S. AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology 2003;65:95-101.   DOI   ScienceOn
2 Kochi M, Fujii M, Kaiga T, Takahashi T, Morishita Y, Kobayashi M, et al. FLEP chemotherapy for alpha-fetoproteinproducing gastric cancer. Oncology 2004;66:445-449.   DOI   ScienceOn
3 Inoue M, Sano T, Kuchiba A, Taniguchi H, Fukagawa T, Katai H. Long-term results of gastrectomy for alpha-fetoproteinproducing gastric cancer. Br J Surg 2010;97:1056-1061.   DOI   ScienceOn
4 Asami T, Kokawa A, Sugimori K, Tomita N, Shirato K, Morimoto M, et al. A case of AFP-producing gastric cancer with multiple liver metastases responding to CPT-11 and cisplatin combination chemotherapy. Gan To Kagaku Ryoho 2002;29:1985- 1988.
5 Yoshioka M, Inoue N, Someda H, Noguchi M, Sawada M, Azuma K, et al. A case of AFP-producing gastric cancer resected after efficient S-1/CDDP combination chemotherapy. Gan To Kagaku Ryoho 2011;38:105-108.
6 Sakurai N, Yamauchi J, Fukushima N, Shibuma H, Ikeda E, Sasou S. A case of non-recurred long-term survival after chemotherapy for liver metastasis of AFP-producing gastric carcinoma. Jpn J Gastroenterol Surg 2005;38:418-423.   DOI
7 Nagahama T, Maruyama M, Toukairin Y, Baba H, Yoshida T, Kure N, et al. Hepatic arterial injection therapy (HAI) for metastatic liver tumor from gastric cancer. Gan To Kagaku Ryoho 2000;27:1920-1923.
8 Takada J, Kenno S, Aoki T, Hamada H, Katsuki Y. A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer. Gan To Kagaku Ryoho 2009;36:2326-2329.
9 Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390.   DOI   ScienceOn
10 Kim C, Lee JL, Choi YH, Kang BW, Ryu MH, Chang HM, et al. Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer. Invest New Drugs 2012;30:306-315.   DOI
11 Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, et al. High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein. Oncology 2000;59:145-151.   DOI   ScienceOn
12 Gao JJ, Inagaki Y, Xue X, Qu XJ, Tang W. c-Met: a potential therapeutic target for hepatocellular carcinoma. Drug Discov Ther 2011;5:2-11.   DOI
13 Chun H, Kwon SJ. Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer 2011;11:23-30.   DOI   ScienceOn
14 Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 2002;19:359-365.   DOI   ScienceOn
15 Ishigami S, Natsugoe S, Nakashima H, Tokuda K, Nakajo A, Okumura H, et al. Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology 2006;53:338-341.